CLINICAL SIGNIFICANCE OF CD33 NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) IN PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH GEMTUZUMAB-OZOGAMICIN-CONTAINING CHEMOTHERAPY

PURPOSE: Purpose of this study was to evaluate clinical implications of CD33 SNPs in pediatric acute myeloid leukemia (AML) patients treated with gemtuzumab ozogamicin (GO) based therapy. EXPERIMENTAL DESIGN: We genotyped four CD33 SNPs: rs35112940 (G>A; Arg304Gly), rs12459419 (C>T; Ala14Val),...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mortland, Leslie, Alonzo, Todd A, Walter, Roland B, Gerbing, Robert B, Mitra, AK, Pollard, Jessica A, Loken, Michael R, Hirsch, Betsy, Raimondi, Susana, Franklin, Janet, Pounds, Stanley, Cao, Xueyuan, Rubnitz, Jeffrey E, Ribeiro, Raul C, Gamis, Alan, Meshinchi, Soheil, Lamba, Jatinder K
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602123/
https://ncbi.nlm.nih.gov/pubmed/23444229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-3115
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים